Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Post Market Study for VasQ, an External Support Implant for Arteriovenous Fistula

NCT: NCT06516653 · RECRUITING

NCT IDNCT06516653
StatusRECRUITING
Start Date2025-01-13
Completion2028-05
SponsorLaminate Medical Technologies (INDUSTRY)
First posted
Last updated

Brief Summary

VasQ is an external support implant for arteriovenous fistulas created for dialysis access. This is a postmarket surveillance, prospective, multi-center, randomized, controlled, open label trial enrolling 300 patients randomized into two study arms: * Treatment arm: End to side fistula supported with VasQ * Control: Standard of care end to side fistula

Frequently Asked Questions

What is Post Market Study for VasQ, an External Support Implant for Arteriovenous Fistula?

Post Market Study for VasQ, an External Support Implant for Arteriovenous Fistula is a clinical trial registered under NCT06516653. Current status: RECRUITING.

What is the status of NCT06516653?

The current status of NCT06516653 (Post Market Study for VasQ, an External Support Implant for Arteriovenous Fistula) is: RECRUITING.

When did Post Market Study for VasQ, an External Support Implant for Arteriovenous Fistula start?

Post Market Study for VasQ, an External Support Implant for Arteriovenous Fistula started on 2025-01-13.

Related Devices

K240119VasQLaminate Medical Technologies , Ltd. PMA P060002System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatmentBard Peripheral Vascular PMA P130029System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatmentBard Peripheral Vascular, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑